The novel therapy of this peptide represents a exciting breakthrough in the handling of the condition. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide505834.blogofchange.com/42687121/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment